Cargando…
Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers
Bone cancers are characterised by the development of tumour cells in bone sites, associated with a dysregulation of their environment. In the last two decades, numerous therapeutic strategies have been developed to target the cancer cells or tumour niche. As the crosstalk between these two entities...
Autores principales: | Ségaliny, Aude I., Tellez-Gabriel, Marta, Heymann, Marie-Françoise, Heymann, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620971/ https://www.ncbi.nlm.nih.gov/pubmed/26579483 http://dx.doi.org/10.1016/j.jbo.2015.01.001 |
Ejemplares similares
-
Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
por: Tellez-Gabriel, Marta, et al.
Publicado: (2019) -
Biology of Bone Sarcomas and New Therapeutic Developments
por: Brown, Hannah K., et al.
Publicado: (2017) -
Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016) -
The Challenges of Detecting Circulating Tumor Cells in Sarcoma
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016) -
Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine
por: Tellez-Gabriel, Marta, et al.
Publicado: (2018)